Russia’s Sputnik V vaccine produced antibodies without “serious adverse effects” in early trials, the medical journal Lancet reports. Researchers say longer and larger trials are needed to prove it safe and effective.

Russia’s Sputnik V vaccine produced antibodies without “serious adverse effects” in early trials, the medical journal Lancet reports. Researchers say longer and larger trials are needed to prove it safe and effective.